Clementine Toussaint
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 22, 2026
Safety and Outcomes of Direct Challenge in Adults With a History of Childhood Penicillin Allergy: A Multicenter Study.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: February 23, 2026
Patch Testing Is Useful in Patients With Lamotrigine-Induced Cutaneous Adverse Drug Reactions.
Journal: Contact dermatitis
Published: January 24, 2026
Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access program.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 14, 2025
Anifrolumab for refractory cutaneous manifestations of amyopathic dermatomyositis.
Journal: Annales de dermatologie et de venereologie
Published: September 19, 2025
Real-life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 09, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study.
Journal: The journal of allergy and clinical immunology. In practice
Published: August 07, 2024
Toxicological screening reveals toxic epidermal necrolysis likely carbamazepine-induced rather than idiopathic.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 19, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026